3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Burkitt Lymphoma
6
Lymphoma, B-Cell
5
Lymphoma
5
Lymphoma, Large B-Cell, Diffuse
3
Recurrence
2
Lymphoma, Non-Hodgkin
2
Hematologic Neoplasms
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Lymphoma, Follicular
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Biphenotypic, Acute
1
Leukemia
1
Blast Crisis
1
Interventions
Imatinib Mesylate
5
nilotinib
4
bosutinib
3
asciminib
2
peginterferon alfa-2a
1
fludarabine phosphate
1
fludarabine
1
Magnetic Resonance Imaging
1
Electrocardiography
1
Echocardiography
1
Diphenhydramine
1
Dasatinib
1
Cyclophosphamide
1
Blood Component Removal
1
Antiemetics
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Philadelphia Chromosome
×
Inotuzumab Ozogamicin
×
Clear all
No trials found.